Stocks and Investing
Stocks and Investing
Mon, August 28, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Ryan Zimmerman Maintained (TMCI) at Strong Buy with Decreased Target to $28 on, Aug 28th, 2023
Ryan Zimmerman of BTIG, Maintained "Treace Medical Concepts, Inc." (TMCI) at Strong Buy with Decreased Target from $32 to $28 on, Aug 28th, 2023.
Ryan has made no other calls on TMCI in the last 4 months.
There are 2 other peers that have a rating on TMCI. Out of the 2 peers that are also analyzing TMCI, 1 agrees with Ryan's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- George Sellers of "Stephens & Co." Maintained at Hold with Decreased Target to $25 on, Thursday, August 10th, 2023
This is the rating of the analyst that currently disagrees with Ryan
- Richard Newitter of "Truist Securities" Maintained at Strong Buy with Decreased Target to $30 on, Wednesday, August 9th, 2023
Contributing Sources